
Researchers Giuseppe Riva, Giulia Brizzi, and Antonino Greco published a groundbreaking Comment in Nature Mental Health proposing the use of artificial intelligence and virtual reality to simulate experiences similar to those produced by traditional psychedelic compounds. While psychedelic-assisted therapy shows promise for mental health treatment, it faces significant regulatory, methodological, and safety challenges. The authors suggest that AI-generated virtual psychedelics could overcome these barriers while maintaining therapeutic benefits. This approach represents a novel intersection of digital technology and psychedelic-assisted therapy modalities, potentially expanding access to these treatments while addressing safety concerns associated with traditional psychedelic compounds.
Original Source
⚠️ Disclaimer: The information in this article is for educational purposes only. Always consult a qualified healthcare professional before making clinical decisions.

New study shows AI-based voice biomarkers can revolutionize depression screening in primary care settings.

JMIR study demonstrates AI-led mental health app is feasible and acceptable among healthcare workers facing burnout.